BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 37796959)

  • 1. Trends in dental expenditures in Japan with a universal health insurance system.
    Sato Y; Fukai K; Kunori Y; Yoshioka E; Saijo Y
    PLoS One; 2023; 18(10):e0292547. PubMed ID: 37796959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Health and dental care expenditures in the United States from 1996 to 2016.
    Hung M; Lipsky MS; Moffat R; Lauren E; Hon ES; Park J; Gill G; Xu J; Peralta L; Cheever J; Prince D; Barton T; Bayliss N; Boyack W; Licari FW
    PLoS One; 2020; 15(6):e0234459. PubMed ID: 32526770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Examination of orthodontic expenditures and trends in the United States from 1996 to 2016: disparities across demographics and insurance payers.
    Hung M; Su S; Hon ES; Tilley E; Macdonald A; Lauren E; Roberson G; Lipsky MS
    BMC Oral Health; 2021 May; 21(1):268. PubMed ID: 34001095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medical expenditures for fragility hip fracture in Japan: a study using the nationwide health insurance claims database.
    Mori T; Komiyama J; Fujii T; Sanuki M; Kume K; Kato G; Mori Y; Ueshima H; Matsui H; Tamiya N; Sugiyama T
    Arch Osteoporos; 2022 Apr; 17(1):61. PubMed ID: 35403938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An analysis of management of private dental clinics in Japan from the survey of the current economy of medicine and dentistry.
    Okada M; Morita M; Watanabe T; Miyatake K
    Bull Tokyo Dent Coll; 1999 May; 40(2):79-91. PubMed ID: 10825818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Age-stratified analysis of the impact of hypertension on National Health Insurance Medical Expenditures in Ibaraki, Japan.
    Sairenchi T; Irie F; Izumi Y; Muto T
    J Epidemiol; 2010; 20(3):192-6. PubMed ID: 20208401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Japanese healthcare system: in vitro diagnostic tests and reimbursements.
    Shimauchi A
    Clin Chem; 1994 Aug; 40(8):1663-7. PubMed ID: 8045026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Past, present, and future of global health financing: a review of development assistance, government, out-of-pocket, and other private spending on health for 195 countries, 1995-2050.
    Global Burden of Disease Health Financing Collaborator Network
    Lancet; 2019 Jun; 393(10187):2233-2260. PubMed ID: 31030984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Welfare analysis of a zero-smoking policy - A case study in Japan.
    Nakamura Y; Takahashi K; Nomura M; Kamei M
    Drug Discov Ther; 2018 Mar; 12(1):37-41. PubMed ID: 29479045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. US Health Care Spending by Payer and Health Condition, 1996-2016.
    Dieleman JL; Cao J; Chapin A; Chen C; Li Z; Liu A; Horst C; Kaldjian A; Matyasz T; Scott KW; Bui AL; Campbell M; Duber HC; Dunn AC; Flaxman AD; Fitzmaurice C; Naghavi M; Sadat N; Shieh P; Squires E; Yeung K; Murray CJL
    JAMA; 2020 Mar; 323(9):863-884. PubMed ID: 32125402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. National health expenditures: a global analysis.
    Murray CJ; Govindaraj R; Musgrove P
    Bull World Health Organ; 1994; 72(4):623-37. PubMed ID: 7923542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prospects for national health expenditure in Japan].
    Sakoi M
    Gan To Kagaku Ryoho; 2000 Aug; 27(9):1337-46. PubMed ID: 10969587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Economic costs of diabetes in the US in 2002.
    Hogan P; Dall T; Nikolov P;
    Diabetes Care; 2003 Mar; 26(3):917-32. PubMed ID: 12610059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spending on health and HIV/AIDS: domestic health spending and development assistance in 188 countries, 1995-2015.
    Global Burden of Disease Health Financing Collaborator Network
    Lancet; 2018 May; 391(10132):1799-1829. PubMed ID: 29678342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hong Kong domestic health spending: financial years 1989/90 to 2011/12.
    Tin KY; Tsoi PK; Lee YH; Chong DS; Lam DW; Yeung AY; Ma ES; Maw CK
    Hong Kong Med J; 2015 Jun; 21(3 Suppl 3):1-24. PubMed ID: 26045183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost impact of COPD in Japan: opportunities and challenges?
    Nishimura S; Zaher C
    Respirology; 2004 Nov; 9(4):466-73. PubMed ID: 15612957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characteristics of older adults who meet the annual prescription drug expenditure threshold for medicare medication therapy management programs.
    Daniel GW; Malone DC
    J Manag Care Pharm; 2007 Mar; 13(2):142-54. PubMed ID: 17330975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ophthalmic Medication Expenditures and Out-of-Pocket Spending: An Analysis of United States Prescriptions from 2007 through 2016.
    Chen EM; Kombo N; Teng CC; Mruthyunjaya P; Nwanyanwu K; Parikh R
    Ophthalmology; 2020 Oct; 127(10):1292-1302. PubMed ID: 32359935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduction of Overwork Time of Nurses by Innovation of Nursing Records Using Structured Clinical Knowledge.
    Tsuru S; Nakao A; Yahagi N; Tanizaki K; Sudo K; Morimatsu S; Takaki T; Takakusaki N; Higashi T; Nakashigeg K; Takahashi M
    Stud Health Technol Inform; 2019 Aug; 264():1061-1064. PubMed ID: 31438087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hong Kong domestic health spending: financial years 1989/90 to 2010/11.
    Tin KY; Tsoi PK; Lee YH; Tsui EL; Lam DW; Yeung AY; Chui AW; Tay MS
    Hong Kong Med J; 2013 Dec; 19(6 Suppl 7):1-24. PubMed ID: 24356244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.